Cite
Pharmacokinetic Modeling of Targeted Ultrasound Contrast Agents for Quantitative Assessment of Anti-Angiogenic Therapy: a Longitudinal Case-Control Study in Colon Cancer
MLA
Amelie M. Lutz, et al. “Pharmacokinetic Modeling of Targeted Ultrasound Contrast Agents for Quantitative Assessment of Anti-Angiogenic Therapy: A Longitudinal Case-Control Study in Colon Cancer.” Molecular Imaging and Biology, vol. 21, no. 4, Sept. 2018, pp. 633–43. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4ca118400163ebb0b914e149d32d036b&authtype=sso&custid=ns315887.
APA
Amelie M. Lutz, Ahmed El Kaffas, Jianhua Zhou, Hessel Wijkstra, Massimo Mischi, Jürgen K. Willmann, & Simona Turco. (2018). Pharmacokinetic Modeling of Targeted Ultrasound Contrast Agents for Quantitative Assessment of Anti-Angiogenic Therapy: a Longitudinal Case-Control Study in Colon Cancer. Molecular Imaging and Biology, 21(4), 633–643.
Chicago
Amelie M. Lutz, Ahmed El Kaffas, Jianhua Zhou, Hessel Wijkstra, Massimo Mischi, Jürgen K. Willmann, and Simona Turco. 2018. “Pharmacokinetic Modeling of Targeted Ultrasound Contrast Agents for Quantitative Assessment of Anti-Angiogenic Therapy: A Longitudinal Case-Control Study in Colon Cancer.” Molecular Imaging and Biology 21 (4): 633–43. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4ca118400163ebb0b914e149d32d036b&authtype=sso&custid=ns315887.